{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR104/063/SRR10418663/SRR10418663.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR104/061/SRR10418661/SRR10418661_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR104/060/SRR10418660/SRR10418660_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR104/059/SRR10418659/SRR10418659_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR104/058/SRR10418658/SRR10418658_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR104/063/SRR10418663/SRR10418663_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR104/062/SRR10418662/SRR10418662_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR104/059/SRR10418659/SRR10418659_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR104/060/SRR10418660/SRR10418660_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR104/062/SRR10418662/SRR10418662.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR104/061/SRR10418661/SRR10418661_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR104/062/SRR10418662/SRR10418662_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR104/063/SRR10418663/SRR10418663_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR104/058/SRR10418658/SRR10418658_2.fastq.gz"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Fox Chase Cancer Center"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA588424"],"long_description":["BRCA1 BRCT domain mutant proteins do not fold correctly and are subject to proteasomal degradation, resulting in PARPi sensitivity."],"repository":["ENA"],"description_synonyms":["RNF53, inhibitors, hereditary breast ovarian cancer, Alu-Like Repetitive Sequence, DmelCG40411, Alu Families, Materials, BRCA1, Alu, BRCA2, LD21673.3prime, BRCAI, pADPRT-1, Gene, inhibitor, PSCP, BEST:LD21673, PPP1R53, Alu Repetitive, Repetitive Sequence, Cistrons, DFNA13, Sequences, Adprt1, PARP1, Repetitive Sequences, CG40411, Sequence, Alu Repetitive Sequence, Alu Repetitive Sequences, sPARP-1, STL3, Familiar breast and Ovarian cancer syndrome, IRIS, Genetic Materials, BROVCA1, C80510, ADPRT, Genetic Material, CG17696, resistance., Element, Drives, Genetic, Adprp, BRCC1, PARP, ARTD1, Elements, ADPRT1, AI893648, PNCA4, Alu Element, inhibiteur, INSDC_feature:gene, adprt1, FANCS, parp, DFNB53, CG17685, CG17718, padprt-1, inhibidor, Alu Family, ppol, Material, Families, FBCG2, ADPRT 1, PARP-1, D.PARP, HKE5, Cistron, dPARP, Dm.pARTa, PPOL, 5830444G22Rik, parp-1, Family"],"additional_accession":[]},"is_claimable":false,"name":"","description":"BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance","dates":{"last_updated":"2023-05-17","first_public":"2019-11-14"},"accession":"PRJNA588424","cross_references":{}}